Phocas Financial’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-292,510
Closed -$3.81M – 15
2026
Q2
$3.81M Sell
292,510
-15,636
-5% -$178K 0.53% 79
2026
Q1
$3.5M Sell
308,146
-298,127
-49% -$3.23M 0.55% 76
2025
Q4
$7.78M Sell
606,273
-1,551
-0.3% -$19.1K 1.01% 32
2025
Q3
$6.79M Buy
607,824
+269,416
+80% +$2.6M 0.88% 48
2025
Q2
$3.36M Buy
338,408
+50
+0% +$489 0.48% 82
2025
Q1
$3.18M Buy
+338,358
New +$3.56M 0.49% 88

Other funds holding ANGO

Phocas Financial's ANGO Position: Q3 2026 in Review

Phocas Financial sold out of AngioDynamics (ANGO) in Q3 2026, closing a stake of 292,510 shares — an estimated $3.81M sold.

Phocas Financial first reported a position in ANGO in Q1 2025 and held it in 6 quarters. The position peaked at $7.78M in Q4 2025. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Phocas Financial reported no remaining AngioDynamics position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 292,510 AngioDynamics shares in Q3 2026, an estimated $3.81M.
  • Phocas Financial first reported a position in AngioDynamics in Q1 2025 and held it in 6 quarters.
  • Phocas Financial's AngioDynamics position peaked at $7.78M in Q4 2025.
  • 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.